Approval · Notice of Compliance 27464 · 2022
MINT-ACYCLOVIR: Notice of Compliance 27464
Issued January 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27464
- Date
- January 25, 2022
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- APO-ACYCLOVIR (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-ACYCLOVIR | 02524708 | Marketed |
| MINT-ACYCLOVIR | 02524716 | Marketed |
| MINT-ACYCLOVIR | 02524724 | Marketed |